pAAV2-CAG-mScarlet-I-Cdt1
(Plasmid
#191100)
-
PurposeTo express a bright monomeric red FP to label eucaryotic cell nuclei. To be used in tissue clearing methods and other fluorescent microscopy methods
-
Depositing Labs
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 191100 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepAAV2-CAG
-
Backbone manufacturerBoyden Laboratory
- Backbone size w/o insert (bp) 4789
- Total vector size (bp) 5797
-
Vector typeMammalian Expression, AAV, Synthetic Biology
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemScarlet-I-Cdt1 (30-120)
-
SpeciesSynthetic
-
Insert Size (bp)1008
-
MutationOptimized to human codon usage
- Promoter CMV enhancer and CAG
-
Tag
/ Fusion Protein
- mScarlet-I fused to residues 30-120 of human Cdt1 gene. FPbase ID: FVS3D (C terminal on insert) (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI, EcoRI (not destroyed)
- 3′ cloning site NheI, EcoRV (not destroyed)
- 5′ sequencing primer pCAGG-5
- 3′ sequencing primer wPRE-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV2-CAG-mScarlet-I-Cdt1 was a gift from Murray Blackmore & Pantelis Tsoulfas (Addgene plasmid # 191100 ; http://n2t.net/addgene:191100 ; RRID:Addgene_191100) -
For your References section:
Brain-wide analysis of the supraspinal connectome reveals anatomical correlates to functional recovery after spinal injury. Wang Z, Romanski A, Mehra V, Wang Y, Brannigan M, Campbell BC, Petsko GA, Tsoulfas P, Blackmore MG. Elife. 2022 Jul 15;11. pii: 76254. doi: 10.7554/eLife.76254. 10.7554/eLife.76254 PubMed 35838234